Artemis Therapeutics Inc.
ATMS News Today: Stay Updated with the Latest Artemis Therapeutics Inc. News in Real Time
Find ATMS news now at Meyka AI. Stay informed with the latest Artemis Therapeutics Inc. stocks updates, including price news, market analysis, and expert insights.
Benchmark Maintains Buy on PGRE (Paramount Group, Inc.) Feb 26, 2026
PGRE analyst rating: Benchmark maintained Buy on Feb 26, 2026; implications, market cap, and Meyka AI grade B
C$0.03 jump: XRApplied Technologies (XRA.CN CNQ) high-volume mover 27 Feb 2026
Market hours update on XRA.CN stock: price C$0.03, volume 35,000 on CNQ; quick analysis and forecast
US Stock Futures Slide as Nvidia Weighs on Wall Street; Netflix Rallies
U.S. stock futures dipped sharply on February 26, 2026, as traders digested a surprise twist in the tech rally. Despite record earnings from Nvidia, the AI chip leader’s shares slid more than 5%, sparking caution across major indexes like the S&P 500 and Nasdaq. At the same time, streaming giant Netflix bucked the trend, rallying…
Jefferies Maintains Hold on Ironwood Pharmaceuticals (IRWD) Feb 26, 2026
Jefferies kept a Hold and raised the PT to $3.70. IRWD analyst rating updated on Feb 26, 2026
Volume spike: EBML eBullion, Inc. (PNK) 27 Feb 2026 market hours, liquidity test
EBML stock fell to $0.0012 on heavy volume; we analyze the spike, liquidity and outlook for traders
Goldman Sachs Maintained Buy on Loar Holdings Inc (LOAR) Feb 26, 2026
Goldman Sachs maintained Buy on Loar Holdings; latest LOAR analyst rating and implications Feb 26, 2026
NASA Astronaut Admits Medical Issue Prompted Crew’s Early Return to Earth
On February 25, 2026, NASA confirmed that a medical issue experienced by an astronaut aboard the International Space Station (ISS) led to an early return of the Crew-11 mission. The unexpected decision marked NASA’s first medical evacuation from the ISS in more than two decades of operations. The crew safely splashed down near San Diego…
LTHM.CN Champion Electric Metals CNQ down 50% on 27 Feb 2026: liquidity risk ahead
LTHM.CN stock falls to CAD 0.005 on CNQ. Quick analysis, Meyka AI forecast and key risks
Jefferies Maintains Buy, PT $45 for Viridian Therapeutics (VRDN) Feb 2026
VRDN analyst rating: Jefferies maintains Buy with $45 PT and Evercore keeps Outperform in Feb 2026